Novartis moves in closer on US eye-care group

Swiss pharmaceutical giant Novartis has confirmed moves to buy a majority stake in eye-care company Alcon with a view to gaining full ownership.

This content was published on January 4, 2010 minutes

The Basel-based group said it would complete purchase of food and drinks company Nestlé's 52 per cent stake and then intended to buy the remaining 23 per cent stake from minority shareholders.

The group said in a statement on Monday that the entire cost of purchasing Nestlé's 77 per cent stake in Alcon shares would be $38.5 billion (SFr39.6 billion).

Novartis bought 25 per cent of Switzerland's Nestlé's Alcon stake for $10 billion in 2008, agreeing then to buy the group's remaining majority stake for $28 billion.

Alcon has its United States headquarters in Fort Worth, Texas, and employs around 15,000 people worldwide. When combined with Novartis, their portfolios would cover 70 per cent of the eye care sector. and agencies

In compliance with the JTI standards

In compliance with the JTI standards

More: SWI certified by the Journalism Trust Initiative

Contributions under this article have been turned off. You can find an overview of ongoing debates with our journalists here. Please join us!

If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at

Share this story

Change your password

Do you really want to delete your profile?